1159826-05-7

Basic information

• Product Name: 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoic acid
• Synonyms: 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoic acid
• CAS NO: 1159826-05-7
• Molecular Weight: 254.248
• Mol File: 1159826-05-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoic acid(1159826-05-7)
• EPA Substance Registry System: 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoic acid(1159826-05-7)

Safety Data

• Hazardous Substances Data: 1159826-05-7(Hazardous Substances Data)

Upstream product

• 1010120-60-1 ethyl [(5-bromopyridin-2-yl)carbamothioyl]carbamate 
• 947248-68-2 6-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine 
• 25487-66-5 3-Carboxyphenylboronic acid 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 1309593-79-0 ethyl 3-(2-amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoate 
• 1309593-80-3 ethyl 3-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}benzoate 
• 1309593-81-4 3-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}benzoic acid 
• 1309681-02-4 3-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}-N-ethylbenzamide 
• 1309593-53-0 2-[(6-{3-[(4-methylpiperazin-1-yl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)amino]benzonitrile 

Relevant articles and documents

TRIAZOLOPYRIDINES

The present invention relates to triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said com

TRIAZOLOPYRIDINES

The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis proliferative of diseases, as well as to intermediate compounds useful in the preparation of said compounds.

Triazolopyridines

The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of proliferative diseases, as well as to intermediate compounds useful in the preparation of said compounds.